RecruitingPhase 3NCT07225686

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Studying ADULT syndrome

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Amgen
Principal Investigator: MD
Amgen
Intervention: Maridebart cafraglutide(drug)
Enrollment: 250 target
Eligibility: 18-99 years · All sexes
Timeline: 2025 – 2028

Study locations (30)

Valley Clinical Trials, Northridge, California, United States
Peninsula Research Associates, Rolling Hills Estates, California, United States
Teradan Clinical Trials, Brandon, Florida, United States
Destiny Research Center, Palmetto Bay, Florida, United States
Clinical Research Center Of Florida, Pompano Beach, Florida, United States
NeuroTrials Research, Atlanta, Georgia, United States
Basil Clinical, Laurelton, New York, United States
Monroe Biomedical Research, Monroe, North Carolina, United States
CTI Clinical Research Center, Cincinnati, Ohio, United States
FutureSearch Trials of Neurology, Austin, Texas, United States
Epic Medical Research - DeSoto, DeSoto, Texas, United States
Sleep Therapy & Research Center, San Antonio, Texas, United States
Northwest Clinical Research Center, Bellevue, Washington, United States
Woolcock Institute of Medical Research, Macquarie Park, New South Wales, Australia
Royal Brisbane and Womens Hospital, Herston, Queensland, Australia
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07225686 on ClinicalTrials.gov

Other trials for ADULT syndrome

Additional recruiting or active studies for the same condition.

See all trials for ADULT syndrome →

← Back to all trials